Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

ARWRARWR
21 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in ARROWHEAD PHARMACEUTICALS IN

STIFEL FINANCIAL CORP holds 73,294 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $6M as of 2026-Q2. The position was increased (+526.7% shares). ARWR represents 0.0% of STIFEL FINANCIAL CORP's portfolio.

Current Value

$6M

Current Shares

73,294

Total Value Change

+$5.7M

Total Shares Change

+48,598

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
73,294
+526.7%
$6M0.0%$81.51
44
2026-Q1
Decreased
11,696
-1.0%
$733,3510.0%$64.10
0
2025-Q4
New
11,811
-
$784,1300.0%$67.25
34
2023-Q1
Exited
0
-100.0%
$00.0%$24.43
0
2022-Q4
Decreased
19,821
-6.8%
$803,9490.0%$40.56
0
2022-Q3
Decreased
21,273
-1.4%
$703,0000.0%$33.28
0
2022-Q2
Decreased
21,579
-1.5%
$760,0000.0%$34.56
0
2022-Q1
Decreased
21,917
-3.5%
$1M0.0%$45.59
0
2021-Q4
Decreased
22,708
-0.6%
$1.5M0.0%$67.35
0
2021-Q3
Decreased
22,853
-0.4%
$1.4M0.0%$60.63
0
2021-Q2
Increased
22,936
+1.7%
$1.9M0.0%$81.50
26
2021-Q1
Increased
22,560
+0.8%
$1.5M0.0%$63.69
26
2020-Q4
Decreased
22,383
-0.4%
$1.7M0.0%$77.43
0
2020-Q3
Increased
22,466
+3.5%
$967,0000.0%$43.42
26
2020-Q2
Decreased
21,701
-7.3%
$937,0000.0%$42.60
0
2020-Q1
Decreased
23,413
-2.3%
$675,0000.0%$28.97
0
2019-Q4
Decreased
23,975
-0.4%
$1.5M0.0%$64.20
0
2019-Q3
Decreased
24,068
-0.1%
$678,0000.0%$26.96
0
2019-Q2
Decreased
24,090
-1.5%
$641,0000.0%$26.50
0
2019-Q1
Decreased
24,468
-0.9%
$450,0000.0%$18.35
0
2018-Q4
New
24,696
-
$306,0000.0%$11.94
32

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used